{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:57:01Z","timestamp":1784357821123,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.colsurfb.2020.111120","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T21:43:37Z","timestamp":1589233417000},"page":"111120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties"],"prefix":"10.1016","volume":"193","author":[{"given":"Ajay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin K.","family":"Hodnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-2190","authenticated-orcid":false,"given":"Sarah","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-859X","authenticated-orcid":false,"given":"Peter","family":"Davern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.colsurfb.2020.111120_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030134","article-title":"Nanocrystals of poorly soluble drugs: drug bioavailability and physicochemical stability","volume":"10","author":"Gigliobianco","year":"2018","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.colsurfb.2020.111120_bib0010","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/j.2042-7158.2010.01030.x","article-title":"Pharmaceutical applications of cyclodextrins: basic science and product development","volume":"62","author":"Loftsson","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.colsurfb.2020.111120_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/pharmaceutics8020016","article-title":"Stabilizing agents for drug nanocrystals: effect on bioavailability","volume":"8","author":"Tuomela","year":"2016","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.colsurfb.2020.111120_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.colsurfb.2020.111120_bib0025","first-page":"304","article-title":"Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability","volume":"9","author":"Khadka","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.colsurfb.2020.111120_bib0030","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1039\/C5NR07161E","article-title":"Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles","volume":"8","author":"Wais","year":"2016","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpharm.2012.10.043","article-title":"Pharmaceutical cocrystals and poorly soluble drugs","volume":"453","author":"Thakuria","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.colsurfb.2020.111120_bib0045","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ejpb.2013.09.007","article-title":"Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs","volume":"85","author":"Vo","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0050","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2012.08.042","article-title":"Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs","volume":"453","author":"Lu","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","article-title":"Lipid-based formulations for oral administration of poorly water-soluble drugs","volume":"453","author":"Mu","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.colsurfb.2020.111120_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.03.038","article-title":"On the size and shape dependence of the solubility of nano-particles in solutions","volume":"430","author":"Kaptay","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0065","series-title":"Physicochemical Principles of Pharmacy","author":"Florence","year":"2020"},{"issue":"12","key":"10.1016\/j.colsurfb.2020.111120_bib0070","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/ja02086a003","article-title":"The rate of solution of solid substances in their own solutions","volume":"19","author":"Noyes","year":"1897","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0075","article-title":"\u00dcber die vermeintliche isomerie des roten und gelben quecksilberoxyds und die Oberfl\u00e4chenspannung fester k\u00f6rper","volume":"34U","author":"Ostwald","year":"1900","journal-title":"Z. Phys. Chem.\/Int. J. Res. Phys. Chem. Chem. Phys."},{"issue":"1\u20132","key":"10.1016\/j.colsurfb.2020.111120_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(02)00150-3","article-title":"Jet milling\u2013a new technique for microparticle preparation","volume":"242","author":"Nykamp","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.112.005660","article-title":"Strategies to address low drug solubility in discovery and development","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0090","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/j.minpro.2004.07.039","article-title":"Comparison of various milling technologies for grinding pharmaceutical powders","volume":"74","author":"Nakach","year":"2004","journal-title":"Int. J. Miner. Process."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation","volume":"62","author":"KECK","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/0378-5173(89)90005-7","article-title":"Effect of grinding on the solid-state stability of cefixime trihydrate","author":"Satoshi","year":"1989","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2020.111120_bib0105","first-page":"291","article-title":"The effect of mechanical comminution on drug stability","volume":"22","author":"Waltersson","year":"1985","journal-title":"Acta Pharm. Suec."},{"issue":"6","key":"10.1016\/j.colsurfb.2020.111120_bib0110","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","article-title":"Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size","volume":"453","author":"Sinha","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"21","key":"10.1016\/j.colsurfb.2020.111120_bib0120","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1021\/la061122t","article-title":"Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization","volume":"22","author":"Matteucci","year":"2006","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120027417","article-title":"Micron-size drug particles: common and novel micronization techniques","volume":"9","author":"Rasenack","year":"2004","journal-title":"Pharm. Dev. Technol."},{"issue":"3","key":"10.1016\/j.colsurfb.2020.111120_bib0130","doi-asserted-by":"crossref","first-page":"036102","DOI":"10.1103\/PhysRevLett.98.036102","article-title":"Ostwald ripening of \u03b2-Carotene nanoparticles","volume":"98","author":"Liu","year":"2007","journal-title":"Phys. Rev. Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2020.111120_bib0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0192623307310946","article-title":"Drug nanoparticles: formulating poorly water-soluble compounds","volume":"36","author":"Merisko-Liversidge","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2010.10.055","article-title":"Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying","author":"Hu","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0145","article-title":"Hydrosols - alternatives for the parenteral application of poorly water soluble drugs","year":"1994","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.colsurfb.2018.12.021","article-title":"Carrier particle mediated stabilization and isolation of valsartan nanoparticles","volume":"175","author":"Kumar","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.colsurfb.2020.111120_bib0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2016.11.045","article-title":"Carrier particle design for stabilization and isolation of drug nanoparticles","volume":"518","author":"Tierney","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0160","doi-asserted-by":"crossref","DOI":"10.1021\/acs.oprd.9b00460","article-title":"Drug loading and dissolution properties of dalcetrapib \u2013 montmorillonite nanocomposite microparticles","author":"Bodn\u00e1r","year":"2020","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.colsurfb.2020.111120_bib0165","series-title":"Foundations of Colloid Science","author":"Hunter","year":"2001"},{"issue":"11","key":"10.1016\/j.colsurfb.2020.111120_bib0170","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/jps.10455","article-title":"Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I","volume":"92","author":"Grzesiak","year":"2003","journal-title":"J. Pharm. Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520303507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776520303507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:56:57Z","timestamp":1760525817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776520303507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"alternative-id":["S0927776520303507"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111120","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modification of the zeta potential of montmorillonite to achieve high active pharmaceutical ingredient nanoparticle loading and stabilization with optimum dissolution properties","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2020.111120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111120"}}